Report Detail
Global Prostate Specific Antigen Market Professional Survey Report 2019
- RnM2839810 |
- 30 January, 2019 |
- Global |
- 106 Pages |
- QYResearch |
- Pharma & Healthcare
The global Prostate Specific Antigen market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Prostate Specific Antigen volume and value at global level, regional level and company level. From a global perspective, this report represents overall Prostate Specific Antigen market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Prostate Specific Antigen in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Prostate Specific Antigen manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Advaxis, Inc.
Aeterna Zentaris Inc.
Bavarian Nordic A/S
Curevac AG
GenSpera, Inc.
Inovio Pharmaceuticals, Inc.
OncBioMune Pharmaceuticals Inc.
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
G-115
INO-5150
ADXS-PSA
AEZS-120
Others
Segment by Application
Prostate Cancer
Metastatic Hormone Refractory Prostate Cancer
Others
Table of Contents
Executive Summary
1 Industry Overview of Prostate Specific Antigen
- 1.1 Definition of Prostate Specific Antigen
- 1.2 Prostate Specific Antigen Segment by Type
- 1.2.1 Global Prostate Specific Antigen Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 G-115
- 1.2.3 INO-5150
- 1.2.4 ADXS-PSA
- 1.2.5 AEZS-120
- 1.2.6 Others
- 1.3 Prostate Specific Antigen Segment by Applications
- 1.3.1 Global Prostate Specific Antigen Consumption Comparison by Applications (2014-2025)
- 1.3.2 Prostate Cancer
- 1.3.3 Metastatic Hormone Refractory Prostate Cancer
- 1.3.4 Others
- 1.4 Global Prostate Specific Antigen Overall Market
- 1.4.1 Global Prostate Specific Antigen Revenue (2014-2025)
- 1.4.2 Global Prostate Specific Antigen Production (2014-2025)
- 1.4.3 North America Prostate Specific Antigen Status and Prospect (2014-2025)
- 1.4.4 Europe Prostate Specific Antigen Status and Prospect (2014-2025)
- 1.4.5 China Prostate Specific Antigen Status and Prospect (2014-2025)
- 1.4.6 Japan Prostate Specific Antigen Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Prostate Specific Antigen Status and Prospect (2014-2025)
- 1.4.8 India Prostate Specific Antigen Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Prostate Specific Antigen
- 2.3 Manufacturing Process Analysis of Prostate Specific Antigen
- 2.4 Industry Chain Structure of Prostate Specific Antigen
3 Development and Manufacturing Plants Analysis of Prostate Specific Antigen
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Prostate Specific Antigen Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Prostate Specific Antigen
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Prostate Specific Antigen Production and Capacity Analysis
- 4.2 Prostate Specific Antigen Revenue Analysis
- 4.3 Prostate Specific Antigen Price Analysis
- 4.4 Market Concentration Degree
5 Prostate Specific Antigen Regional Market Analysis
- 5.1 Prostate Specific Antigen Production by Regions
- 5.1.1 Global Prostate Specific Antigen Production by Regions
- 5.1.2 Global Prostate Specific Antigen Revenue by Regions
- 5.2 Prostate Specific Antigen Consumption by Regions
- 5.3 North America Prostate Specific Antigen Market Analysis
- 5.3.1 North America Prostate Specific Antigen Production
- 5.3.2 North America Prostate Specific Antigen Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Prostate Specific Antigen Import and Export
- 5.4 Europe Prostate Specific Antigen Market Analysis
- 5.4.1 Europe Prostate Specific Antigen Production
- 5.4.2 Europe Prostate Specific Antigen Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Prostate Specific Antigen Import and Export
- 5.5 China Prostate Specific Antigen Market Analysis
- 5.5.1 China Prostate Specific Antigen Production
- 5.5.2 China Prostate Specific Antigen Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Prostate Specific Antigen Import and Export
- 5.6 Japan Prostate Specific Antigen Market Analysis
- 5.6.1 Japan Prostate Specific Antigen Production
- 5.6.2 Japan Prostate Specific Antigen Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Prostate Specific Antigen Import and Export
- 5.7 Southeast Asia Prostate Specific Antigen Market Analysis
- 5.7.1 Southeast Asia Prostate Specific Antigen Production
- 5.7.2 Southeast Asia Prostate Specific Antigen Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Prostate Specific Antigen Import and Export
- 5.8 India Prostate Specific Antigen Market Analysis
- 5.8.1 India Prostate Specific Antigen Production
- 5.8.2 India Prostate Specific Antigen Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Prostate Specific Antigen Import and Export
6 Prostate Specific Antigen Segment Market Analysis (by Type)
- 6.1 Global Prostate Specific Antigen Production by Type
- 6.2 Global Prostate Specific Antigen Revenue by Type
- 6.3 Prostate Specific Antigen Price by Type
7 Prostate Specific Antigen Segment Market Analysis (by Application)
- 7.1 Global Prostate Specific Antigen Consumption by Application
- 7.2 Global Prostate Specific Antigen Consumption Market Share by Application (2014-2019)
8 Prostate Specific Antigen Major Manufacturers Analysis
- 8.1 Advaxis, Inc.
- 8.1.1 Advaxis, Inc. Prostate Specific Antigen Production Sites and Area Served
- 8.1.2 Advaxis, Inc. Product Introduction, Application and Specification
- 8.1.3 Advaxis, Inc. Prostate Specific Antigen Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Aeterna Zentaris Inc.
- 8.2.1 Aeterna Zentaris Inc. Prostate Specific Antigen Production Sites and Area Served
- 8.2.2 Aeterna Zentaris Inc. Product Introduction, Application and Specification
- 8.2.3 Aeterna Zentaris Inc. Prostate Specific Antigen Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Bavarian Nordic A/S
- 8.3.1 Bavarian Nordic A/S Prostate Specific Antigen Production Sites and Area Served
- 8.3.2 Bavarian Nordic A/S Product Introduction, Application and Specification
- 8.3.3 Bavarian Nordic A/S Prostate Specific Antigen Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Curevac AG
- 8.4.1 Curevac AG Prostate Specific Antigen Production Sites and Area Served
- 8.4.2 Curevac AG Product Introduction, Application and Specification
- 8.4.3 Curevac AG Prostate Specific Antigen Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 GenSpera, Inc.
- 8.5.1 GenSpera, Inc. Prostate Specific Antigen Production Sites and Area Served
- 8.5.2 GenSpera, Inc. Product Introduction, Application and Specification
- 8.5.3 GenSpera, Inc. Prostate Specific Antigen Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Inovio Pharmaceuticals, Inc.
- 8.6.1 Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Production Sites and Area Served
- 8.6.2 Inovio Pharmaceuticals, Inc. Product Introduction, Application and Specification
- 8.6.3 Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 OncBioMune Pharmaceuticals Inc.
- 8.7.1 OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Production Sites and Area Served
- 8.7.2 OncBioMune Pharmaceuticals Inc. Product Introduction, Application and Specification
- 8.7.3 OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
9 Development Trend of Analysis of Prostate Specific Antigen Market
- 9.1 Global Prostate Specific Antigen Market Trend Analysis
- 9.1.1 Global Prostate Specific Antigen Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Prostate Specific Antigen Regional Market Trend
- 9.2.1 North America Prostate Specific Antigen Forecast 2019-2025
- 9.2.2 Europe Prostate Specific Antigen Forecast 2019-2025
- 9.2.3 China Prostate Specific Antigen Forecast 2019-2025
- 9.2.4 Japan Prostate Specific Antigen Forecast 2019-2025
- 9.2.5 Southeast Asia Prostate Specific Antigen Forecast 2019-2025
- 9.2.6 India Prostate Specific Antigen Forecast 2019-2025
- 9.3 Prostate Specific Antigen Market Trend (Product Type)
- 9.4 Prostate Specific Antigen Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Prostate Specific Antigen Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Prostate Specific Antigen . Industry analysis & Market Report on Prostate Specific Antigen is a syndicated market report, published as Global Prostate Specific Antigen Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Prostate Specific Antigen market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
